The concentration of VEGF-A in serum was found to be in the range of 133–1657 pg/mL for control subjects and patients with ischemic and hemorrhagic strokes [30], and mean serum values of sNRP-1 were reported by Rachner at 1.88  ±  0.52 nmol/L (= 130.83  ±  36.24 ng/mL) for patients with breast cancer [15]. This evidence concerns the gene VEGFA and breast carcinoma.